Literature DB >> 1164829

Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size.

A R Feinstein.   

Abstract

Mesh：

Year:  1975        PMID： 1164829     DOI： 10.1002/cpt1975184491

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  11 in total

1.  Metronidazole versus placebo in the treatment of gaseous discomfort in patients having an ileostomy. A double-blind cross-over investigation.

Authors:  V Funder; B Ottsen; J Kjaergaard
Journal:  Int J Colorectal Dis       Date:  1988-03       Impact factor: 2.571

2.  Ketanserin in the treatment of traumatic vasospastic disease.

Authors:  V H Larsen; J Fabricius; G Nielsen; K S Hansen
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

3.  Sample size for monitoring of toxic chemical sites.

Authors:  J R Alldredge
Journal:  Environ Monit Assess       Date:  1987-09       Impact factor: 2.513

4.  When can 'non significantly different' treatments be considered as 'equivalent'?

Authors:  A Spriet; D Beiler
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

5.  Immunization of elderly people with two doses of influenza vaccine.

Authors:  P A Gross; M E Weksler; G V Quinnan; R G Douglas; P F Gaerlan; C R Denning
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

6.  Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer.

Authors:  J C Duche; C Joanne; J Barre; H de Cremoux; J C Dalphin; A Depierre; P Brochard; J P Tillement; P Bechtel
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

7.  Morbidity in diabetic and non-diabetic patients after major vascular surgery.

Authors:  A Hjortrup; B F Rasmussen; H Kehlet
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

Review 8.  Drug treatment of epilepsy: a review.

Authors:  D Rosenbloom; A R Upton
Journal:  Can Med Assoc J       Date:  1983-02-01       Impact factor: 8.262

9.  A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.

Authors:  T Ishizaki; Y Oyama; T Suganuma; T Sasaki; H Nakaya; T Shibuya; T Sato
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

10.  Prominent medical journals often provide insufficient information to assess the validity of studies with negative results.

Authors:  Randy S Hebert; Scott M Wright; Robert S Dittus; Tom A Elasy
Journal:  J Negat Results Biomed       Date:  2002-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.